![Kevin Coveney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Coveney
Finanzdirektor/CFO bei
ENVERIC BIOSCIENCES, INC.
Vermögen: 51 $ am 31.08.2026
Profil
Kevin M.
Coveney is the founder of Coveney Capital Advisors LLC, founded in 2020, where the title held was Chief Financial Officer from 2020 to 2022.
Mr. Coveney is currently Chief Financial Officer at Enveric Biosciences, Inc., starting in 2023.
Former jobs include Chief Financial Officer at Memgen, Inc. from 2021 to 2022; Senior Vice President-Finance, HR & IT at Vedanta Biosciences, Inc. from 2018 to 2020; Chief Financial Officer at Q-State Biosciences, Inc. from 2020 to 2021; and Audit Partner at Braver PC from 2007 to 2012.
Education includes undergraduate studies at the University of Massachusetts.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 37 ( 0 % ) | 51 $ | 31.08.2026 |
Aktive Positionen von Kevin Coveney
| Unternehmen | Position | Beginn |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Finanzdirektor/CFO | 13.03.2023 |
Ehemalige bekannte Positionen von Kevin Coveney
| Unternehmen | Position | Ende |
|---|---|---|
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Finanzdirektor/CFO | 01.06.2022 |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Finanzdirektor/CFO | 01.04.2021 |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Finanzdirektor/CFO | 01.02.2020 |
Braver PC
 Braver PC Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01.10.2012 |
Ausbildung von Kevin Coveney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Braver PC
Braver PC Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Health Technology |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
